Larry Seidman

Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO)

Ronald Emkey, William Koltun, Kathleen Beusterien et al. · Current Medical Research and Opinion · 2005 · 171 citations

Medicine, Pharmacology, Pharmacotherapy +16

A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopause

David F. Archer, Larry Seidman, Ginger D. Constantine et al. · American Journal of Obstetrics and Gynecology · 2008 · 93 citations

Medicine, Pharmacology, Pharmacotherapy +14

A multicenter, prospective, open-label study of tolterodine extended-release 4 mg for overactive bladder: The speed of onset of therapeutic assessment trial (STAT)

Paul Siami, Larry Seidman, Daniel Lama · Clinical Therapeutics · 2002 · 51 citations

Medicine, Pharmacology, Urology +10

Efficacy of Rizatriptan for Menstrual Migraine in an Early Intervention Model: A Prospective Subgroup Analysis of the Rizatriptan TAME (Treat A Migraine Early) Studies

Vincent T. Martin, Roger Cady, Alexander Mauskop et al. · Headache The Journal of Head and Face Pain · 2007 · 39 citations

Medicine, Pharmacology, Pharmacotherapy +16

An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis.

Larry Seidman, Campbell K. Skokos · PubMed · 2005 · 27 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17